Commercial Flooring Market Analysis By Product (Soft Coverings, Resilient, Non-resilient, Seamless, Wood & Laminates), By Application, By Region, And Segment Forecasts, 2014 - 2025
出 版 商：Grand View Research Inc.
出版日期：2017/05/10
頁 數：330頁
文件格式：PDF
價 格：
USD 4,950 (Single-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
The global commercial flooring market is expected to reach approximately USD 47.69 billion by 2025, according to a new report conducted by Grand View Research, Inc. Increasing number of corporate offices in emerging economies including China, India, and Mexico on account of regulatory inclination to promote the manufacturing output on a domestic level is expected to remain a key driving factor over the next eight years.
Furthermore, rising government spending towards improving education infrastructure through implementation of new schemes including Padhe Bharat Badhe Bharat and Utkarsh Bangla Scheme is expected to have a strong impact. These factors are considered to influence the consumption of construction materials including floor coverings in education sector and hence boost their market growth.
Education segment is expected to foresee volume growth at a CAGR of 5.9% from 2017 to 2025. Growing importance of modular tiles in education spaces for providing moisture resistance and excellent dust control characteristics is projected to have a positive impact on industry. In addition, high market visibility of carpets in developing countries including China and India on account of the presence of large number soft covering manufacturers on a domestic level is projected to have a positive impact.
Further key findings from the report suggest:
‧ The global commercial flooring market was 4,680.0 million square meters in 2016 and is expected to reach 7,903.4 million square meters by the end of 2025, expanding at a CAGR of 6.0% from 2017 to 2025.
‧ Wood & laminates are expected to foresee revenue growth at a CAGR of 7.0% from 2017 to 2025. Engineered wood, alternately called as composite wood consist of a number of wood products manufactured by binding particles, fibers, veneers, and strands of wood, which are joined with adhesives to form composite materials. These products are modeled to supreme design requirements as per the specifications of end user or client and are tested to meet international and national standards
‧ Asia Pacific is projected to foresee volume growth at a CAGR of 6.9% from 2017 to 2025. Regulatory support aimed at promoting investments in manufacturing sectors of China and India is expected to increase the number of commercial spaces and thus likely to fuel the demand for floor covering in the near future.
‧ Key commercial flooring manufacturers include Mannington Mills, Tarkett, Flowcrete, James Halstead, Nora, Milliken Floor Covering, Novalis, Tajima, Tkflor, NOX Corporation, and Toli flooring. Product innovation through introduction of new designs is expected to remain a key critical success factors for floor covering vendors.
Furthermore, rising government spending towards improving education infrastructure through implementation of new schemes including Padhe Bharat Badhe Bharat and Utkarsh Bangla Scheme is expected to have a strong impact. These factors are considered to influence the consumption of construction materials including floor coverings in education sector and hence boost their market growth.
Education segment is expected to foresee volume growth at a CAGR of 5.9% from 2017 to 2025. Growing importance of modular tiles in education spaces for providing moisture resistance and excellent dust control characteristics is projected to have a positive impact on industry. In addition, high market visibility of carpets in developing countries including China and India on account of the presence of large number soft covering manufacturers on a domestic level is projected to have a positive impact.
Further key findings from the report suggest:
‧ The global commercial flooring market was 4,680.0 million square meters in 2016 and is expected to reach 7,903.4 million square meters by the end of 2025, expanding at a CAGR of 6.0% from 2017 to 2025.
‧ Wood & laminates are expected to foresee revenue growth at a CAGR of 7.0% from 2017 to 2025. Engineered wood, alternately called as composite wood consist of a number of wood products manufactured by binding particles, fibers, veneers, and strands of wood, which are joined with adhesives to form composite materials. These products are modeled to supreme design requirements as per the specifications of end user or client and are tested to meet international and national standards
‧ Asia Pacific is projected to foresee volume growth at a CAGR of 6.9% from 2017 to 2025. Regulatory support aimed at promoting investments in manufacturing sectors of China and India is expected to increase the number of commercial spaces and thus likely to fuel the demand for floor covering in the near future.
‧ Key commercial flooring manufacturers include Mannington Mills, Tarkett, Flowcrete, James Halstead, Nora, Milliken Floor Covering, Novalis, Tajima, Tkflor, NOX Corporation, and Toli flooring. Product innovation through introduction of new designs is expected to remain a key critical success factors for floor covering vendors.
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Infection Control Market - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.6 Industry Analysis - Porter’s Five Forces Model
Chapter 4 Infection Control Market: Type Estimates & Trend Analysis
4.1 Infection Control Market: Type Movement Analysis
4.2 Equipment
4.2.1 Equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2 Disinfectors
4.2.2.1 Disinfectors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.2 Washers
4.2.2.2.1 Washers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.3 Flushers
4.2.2.3.1 Flushers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.4 Endoscope reprocessors
4.2.2.4.1 Endoscope reprocessors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3 Sterilization equipment
4.2.3.1 Sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.2 Heat sterilization equipment
4.2.3.2.1 Heat sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.3 Low temperature equipment
4.2.3.3.1 Low temperature equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.4 Radiation sterilization equipment
4.2.3.4.1 Radiation sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.5 Filtration sterilization equipment
4.2.3.5.1 Filtration sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.6 Liquid sterilization equipment
4.2.3.6.1 Liquid sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3 Services
4.3.1 Services market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2 Contract sterilization
4.3.2.1 Contract sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.2 Ethylene oxide sterilization
4.3.2.2.1 Ethylene oxide sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.3 E-beam sterilization
4.3.2.3.1 E-beam sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.4 Gamma sterilization
4.3.2.4.1 Gamma sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.3 Waste disposal
4.3.3.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4 Consumables
4.4.1 Consumables market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.2 Waste disposal
4.4.2.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.3 Disinfectants
4.4.3.1 Disinfectants market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.4 Sterilization supplies
4.4.4.1 Sterilization supplies market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.5 Personal protective equipment
4.4.5.1 Personal protective equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.6 Others
4.4.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 5 Infection Control Market: End-use Estimates & Trend Analysis
5.1 Infection Control Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Billion)
5.3 Medical Device Companies
5.3.1 Medical device companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.4 Clinical Laboratories
5.4.1 Clinical laboratories market estimates and forecasts, 2014 - 2025 (USD Billion)
5.5 Pharmaceutical Companies
5.5.1 Pharmaceutical companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.6 Others
5.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 6 Infection Control Market: Regional Estimates & Trend Analysis, by Type & End-Use
6.1 Infection Control Market Shares by Region, 2016 & 2025
6.2 North America
6.2.1 North America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.2 North America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.3 U.S.
6.2.3.1 U.S. infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.3.2 U.S. infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.4 Canada
6.2.4.1 Canada infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.4.2 Canada infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.2 Europe infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.3.2 Germany infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.4 UK
6.3.4.1 UK infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.4.2 UK infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.2 Asia Pacific infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.3.2 Japan infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.4 China
6.4.4.1 China infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.4.2 China infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.5 India
6.4.5.1 India infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.5.2 India infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.2 Latin America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.3 Brazil
6.5.3.1 Brazil infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.3.2 Brazil infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.4 Mexico
6.5.4.1 Mexico infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.4.2 Mexico infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6 MEA
6.6.1 MEA infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.2 MEA infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6.2.1 MEA infection control market estimates and forecasts, 2014 - 2025 (USD Billion)
6.6.3 South Africa
6.6.3.1 South Africa infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.3.2 South Africa infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 3M Company
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Belimed AG
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Halyard Health, Inc.
7.3.3.1 Company overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Getinge Group
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Advanced Sterilization Products
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Matchana Group
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Sterigenics International
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 MMM Group
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cantel Medical Corporation
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 STERUS Corporation
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
Chapter 8. Company Profiles
8.1. Amtico
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. The Armstrong Flooring, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Changzhou Liberty Diseno New Material Co., Ltd. (CNBM)
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Congoleum
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Flowcrete (RPM)
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Forbo International SA
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Gerflor
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Hanwha
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Interface Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. IVC Group
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. James Halstead Plc.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. LG Hausys
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Mannington Mills Inc.
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Milliken
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Mohawk Industries
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
8.16. Nora Systems
8.16.1. Company Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Strategic Initiatives
8.17. Novalis
8.17.1. Company Overview
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Strategic Initiatives
8.18. NOX Corporation
8.18.1. Company Overview
8.18.2. Financial Performance
8.18.3. Product Benchmarking
8.18.4. Strategic Initiatives
8.19. Pergo
8.19.1. Company Overview
8.19.2. Financial Performance
8.19.3. Product Benchmarking
8.19.4. Strategic Initiatives
8.20. Polyflor Ltd.
8.20.1. Company Overview
8.20.2. Financial Performance
8.20.3. Product Benchmarking
8.20.4. Strategic Initiatives
8.21. Shanghai Da Julong New Material Co. Ltd
8.21.1. Company Overview
8.21.2. Financial Performance
8.21.3. Product Benchmarking
8.21.4. Strategic Initiatives
8.22. Shaw Industries Group, Inc.,
8.22.1. Company Overview
8.22.2. Financial Performance
8.22.3. Product Benchmarking
8.22.4. Strategic Initiatives
8.23. TAJ Flooring, Inc.
8.23.1. Company Overview
8.23.2. Financial Performance
8.23.3. Product Benchmarking
8.23.4. Strategic Initiatives
8.24. TKflor
8.24.1. Company Overview
8.24.2. Financial Performance
8.24.3. Product Benchmarking
8.24.4. Strategic Initiatives
8.25. TOLI Corporation
8.25.1. Company Overview
8.25.2. Financial Performance
8.25.3. Product Benchmarking
8.25.4. Strategic Initiatives
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Infection Control Market - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.6 Industry Analysis - Porter’s Five Forces Model
Chapter 4 Infection Control Market: Type Estimates & Trend Analysis
4.1 Infection Control Market: Type Movement Analysis
4.2 Equipment
4.2.1 Equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2 Disinfectors
4.2.2.1 Disinfectors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.2 Washers
4.2.2.2.1 Washers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.3 Flushers
4.2.2.3.1 Flushers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.4 Endoscope reprocessors
4.2.2.4.1 Endoscope reprocessors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3 Sterilization equipment
4.2.3.1 Sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.2 Heat sterilization equipment
4.2.3.2.1 Heat sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.3 Low temperature equipment
4.2.3.3.1 Low temperature equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.4 Radiation sterilization equipment
4.2.3.4.1 Radiation sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.5 Filtration sterilization equipment
4.2.3.5.1 Filtration sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.6 Liquid sterilization equipment
4.2.3.6.1 Liquid sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3 Services
4.3.1 Services market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2 Contract sterilization
4.3.2.1 Contract sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.2 Ethylene oxide sterilization
4.3.2.2.1 Ethylene oxide sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.3 E-beam sterilization
4.3.2.3.1 E-beam sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.4 Gamma sterilization
4.3.2.4.1 Gamma sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.3 Waste disposal
4.3.3.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4 Consumables
4.4.1 Consumables market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.2 Waste disposal
4.4.2.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.3 Disinfectants
4.4.3.1 Disinfectants market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.4 Sterilization supplies
4.4.4.1 Sterilization supplies market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.5 Personal protective equipment
4.4.5.1 Personal protective equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.6 Others
4.4.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 5 Infection Control Market: End-use Estimates & Trend Analysis
5.1 Infection Control Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Billion)
5.3 Medical Device Companies
5.3.1 Medical device companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.4 Clinical Laboratories
5.4.1 Clinical laboratories market estimates and forecasts, 2014 - 2025 (USD Billion)
5.5 Pharmaceutical Companies
5.5.1 Pharmaceutical companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.6 Others
5.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 6 Infection Control Market: Regional Estimates & Trend Analysis, by Type & End-Use
6.1 Infection Control Market Shares by Region, 2016 & 2025
6.2 North America
6.2.1 North America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.2 North America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.3 U.S.
6.2.3.1 U.S. infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.3.2 U.S. infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.4 Canada
6.2.4.1 Canada infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.4.2 Canada infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.2 Europe infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.3.2 Germany infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.4 UK
6.3.4.1 UK infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.4.2 UK infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.2 Asia Pacific infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.3.2 Japan infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.4 China
6.4.4.1 China infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.4.2 China infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.5 India
6.4.5.1 India infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.5.2 India infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.2 Latin America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.3 Brazil
6.5.3.1 Brazil infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.3.2 Brazil infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.4 Mexico
6.5.4.1 Mexico infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.4.2 Mexico infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6 MEA
6.6.1 MEA infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.2 MEA infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6.2.1 MEA infection control market estimates and forecasts, 2014 - 2025 (USD Billion)
6.6.3 South Africa
6.6.3.1 South Africa infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.3.2 South Africa infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 3M Company
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Belimed AG
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Halyard Health, Inc.
7.3.3.1 Company overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Getinge Group
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Advanced Sterilization Products
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Matchana Group
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Sterigenics International
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 MMM Group
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cantel Medical Corporation
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 STERUS Corporation
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
Chapter 8. Company Profiles
8.1. Amtico
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. The Armstrong Flooring, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Changzhou Liberty Diseno New Material Co., Ltd. (CNBM)
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Congoleum
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Flowcrete (RPM)
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Forbo International SA
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Gerflor
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Hanwha
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Interface Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. IVC Group
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. James Halstead Plc.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. LG Hausys
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Mannington Mills Inc.
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Milliken
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Mohawk Industries
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
8.16. Nora Systems
8.16.1. Company Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Strategic Initiatives
8.17. Novalis
8.17.1. Company Overview
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Strategic Initiatives
8.18. NOX Corporation
8.18.1. Company Overview
8.18.2. Financial Performance
8.18.3. Product Benchmarking
8.18.4. Strategic Initiatives
8.19. Pergo
8.19.1. Company Overview
8.19.2. Financial Performance
8.19.3. Product Benchmarking
8.19.4. Strategic Initiatives
8.20. Polyflor Ltd.
8.20.1. Company Overview
8.20.2. Financial Performance
8.20.3. Product Benchmarking
8.20.4. Strategic Initiatives
8.21. Shanghai Da Julong New Material Co. Ltd
8.21.1. Company Overview
8.21.2. Financial Performance
8.21.3. Product Benchmarking
8.21.4. Strategic Initiatives
8.22. Shaw Industries Group, Inc.,
8.22.1. Company Overview
8.22.2. Financial Performance
8.22.3. Product Benchmarking
8.22.4. Strategic Initiatives
8.23. TAJ Flooring, Inc.
8.23.1. Company Overview
8.23.2. Financial Performance
8.23.3. Product Benchmarking
8.23.4. Strategic Initiatives
8.24. TKflor
8.24.1. Company Overview
8.24.2. Financial Performance
8.24.3. Product Benchmarking
8.24.4. Strategic Initiatives
8.25. TOLI Corporation
8.25.1. Company Overview
8.25.2. Financial Performance
8.25.3. Product Benchmarking
8.25.4. Strategic Initiatives
